glp-1 gip therapies weight management effectiveness Frontiers ✨ Non-Surgical Weight Loss Treatments

Compounded GLP-1s are produced in FDA-registered facilities but have not been evaluated by the FDA for safety, efficacy or quality

Pain Ther 13(3):609620

doi: 10.1124/jpet.105.093104

We do not push anyone in either direction

[11] Hexarelins Potential Cardiac Protective Effects Another distinctive potential of hexarelin is its interaction with innate CD36 receptors

However, these trials concentrated on cardiovascular outcomes rather than ocular ones, with inconsistent definitions and grading, rendering them insufficient for evaluating the long-term stabilization or enhancement of retinal pathology following an acute reduction in glycosylated hemoglobin (HbA1c)